Echothiophate
- Generic Name
- Echothiophate
- Brand Names
- Phospholine Iodide
- Drug Type
- Small Molecule
- Chemical Formula
- C9H23NO3PS
- CAS Number
- 6736-03-4
- Unique Ingredient Identifier
- 0F350BVT6S
- Background
A potent, long-acting irreversible cholinesterase inhibitor used as an ocular hypertensive in the treatment of glaucoma. Occasionally used for accomodative esotropia.
- Indication
For use in the treatment of subacute or chronic angle-closure glaucoma after iridectomy or where surgery is refused or contraindicated.
- Associated Conditions
- Accommodative component in esotropia, Chronic Angle Closure Glaucoma, Open Angle Glaucoma (OAG), Nonuveitic secondary glaucoma
Echothiophate Iodide for the Prevention of Progression of Myopia
Phase 4
Withdrawn
- Conditions
- Myopia
- Interventions
- First Posted Date
- 2015-09-09
- Last Posted Date
- 2025-02-07
- Lead Sponsor
- Danbury Eye Physicians & Surgeons, PC
- Target Recruit Count
- 33
- Registration Number
- NCT02544529
- Locations
- 🇺🇸
Danbury Eye Physicians & Surgeons, PC, Danbury, Connecticut, United States
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2025. All Rights Reserved by MedPath